Dr Elaine Siegfried on Preventive Strategies to Reduce Comorbidity Risk in Atopic Dermatitis
Controlling atopic dermatitis early on with novel drugs that address the primary immune dysfunction of the disease can have a disease-modifying impact in reducing risk of comorbid conditions, said Elaine...
Discussion: We may in fact be into a new era of disease-modifying anti-inflammatory medications.
The Atopic March and Beyond - Other Health Issues Connected with Atopic Dermatitis
Source : https://nationaleczema.org/blog/beyond-the-atopic-march/
Scientific studies and patient testimonials have firmly demonstrated that atopic dermatitis (AD) is much more than a skin disease, with impacts that can affect virtually every aspect of life. In...
Discussion: Active areas of current research are sorting out which diseases and symptoms are truly co-associated with AD and understanding how the contributing biological mechanisms and factors like environment, genetics and patient demographics impact development of comorbidities.
Dr Robert Sidbury on Promoting Therapeutic Adherence in Pediatric Atopic Dermatitis
Adherence of topical and oral drugs for the treatment of atopic dermatitis (AD) in children can be difficult, but there are several strategies that can promote uptake, said Robert Sidbury,...
Discussion: “With oral medications, any oral medication, I try to get older kids to time it with something they do every day. If it's a medication we'd like them to take with food well then always pair it with breakfast or dinner or something that they won't forget.”
Skin Barrier Abnormalities in Atopic Dermatitis - Current Treatment Options in Allergy
Source : https://link.springer.com/article/10.1007/s40521-022-00310-9
Purpose of Review Atopic dermatitis (AD) is a common, inflammatory, relapsing skin disease with intense itch. The disease affects approximately 20% of children and up to 10% of adults in...
Conclusion: Most new therapeutic options are aimed at inhibiting the inflammatory pathway and thereby improving the function of the epidermal barrier. Moreover, research is indicating that improved emollients will also be a part of the future treatment options for AD patients.
Melatonin and Sleep Disturbances in Children With Atopic Dermatitis | CCID
Source : https://doi.org/10.2147/CCID.S366854
Atopic dermatitis (AD; atopic eczema - AE) is a chronic, recurrent, common inflammatory skin disease, characterized by periods of exacerbation and remission. The disease manifests itself as an intense itching...
Conclusion: Children with moderate AD have impaired sleep quality and lower melatonin levels compared to controls. No correlation was found between melatonin levels and CSHQ, as well as melatonin levels and SCORAD, although there was a strong and significant correlation between SCORAD and CSHQ. Therefore, melatonin levels may not be the main...